Prognostic value of miR17-92 family in patients with digestive system cancers: a systematic review and meta-analysis

References

• SiegelRLMillerKDJemalACancer statistics, 2017CA Cancer J Clin201767173028055103
   PubMed Web of Science ®Google Scholar
• FerlayJSoerjomataramIDikshitRCancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012Int J Cancer20151365E359E38625220842
   PubMed Web of Science ®Google Scholar
• SvoronosAAEngelmanDMSlackFJOncomiR or tumor suppressor? The Duplicity of microRNAs in cancerCancer Res201676133666367027325641
   PubMed Web of Science ®Google Scholar
• Perez-GraciaJLSanmamedMFBoschAStrategies to design clinical studies to identify predictive biomarkers in cancer researchCancer Treat Rev201753799728088073
   PubMed Web of Science ®Google Scholar
• LeichterALSullivanMJEcclesMRChatterjeeAMicroRNA expression patterns and signalling pathways in the development and progression of childhood solid tumoursMol Cancer20171611528103887
   PubMedGoogle Scholar
• ChangCCYangYJLiYJCorrigendum to “MicroRNA-17/20a functions to inhibit cell migration and can be used a prognostic marker in oral squamous cell carcinoma” [Oral Oncol. 49(9) (2013) 923-931]Oral Oncol20177220220328711305
   PubMed Web of Science ®Google Scholar
• CalinGADumitruCDShimizuMFrequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lym-phocytic leukemiaProc Natl Acad Sci USA20029924155241552912434020
   PubMed Web of Science ®Google Scholar
• PengYCroceCMThe role of microRNAs in human cancerSignal Transduct Target Ther2016111500429263891
   PubMedGoogle Scholar
• Valencia-SanchezMALiuJHannonGJParkerRControl of translation and mRNA degradation by miRNAs and siRNAsGenes Dev200620551552416510870
   PubMed Web of Science ®Google Scholar
• TakasakiSRoles of microRNAs in cancers and developmentMethods Mol Biol2015121837541325319665
   PubMedGoogle Scholar
• BobbiliMRMaderRMGrillariJDellagoHOncomiR-17-5p: alarm signal in cancer?Oncotarget2017841712067122229050357
   PubMedGoogle Scholar
• LuSWangSGengSMaSLiangZJiaoBIncreased expression of microRNA-17 predicts poor prognosis in human gliomaJ Biomed Biotechnol2012201261621836813
   PubMedGoogle Scholar
• RobainaMCFaccionRSMazzoccoliLMiR-17-92 cluster components analysis in Burkitt lymphoma: overexpression of miR-17 is associated with poor prognosisAnn Hematol201695688189127044389
   PubMed Web of Science ®Google Scholar
• ChenQSiQXiaoSPrognostic significance of serum miR-17-5p in lung cancerMed Oncol201330135323263848
   PubMed Web of Science ®Google Scholar
• LiXYangHTianQLiuYWengYUpregulation of microRNA-17-92 cluster associates with tumor progression and prognosis in osteosarcomaNeoplasma2014610445346024645838
   PubMedGoogle Scholar
• FedeliMRibaMGarcia ManteigaJMmiR-17~92 family clusters control iNKT cell ontogenesis via modulation of TGF-β signalingProc Natl Acad Sci USA201611351E8286E829527930306
   PubMed Web of Science ®Google Scholar
• LiJLaiYMaJmiR-17-5p suppresses cell proliferation and invasion by targeting ETV1 in triple-negative breast cancerBMC Cancer201717174529126392
   PubMed Web of Science ®Google Scholar
• WangMGuHWangSCirculating miR-17-5p and miR-20a: molecular markers for gastric cancerMol Med Rep201256151422406928
   PubMed Web of Science ®Google Scholar
• XueTMTaoLDZhangMXuGCZhangJZhangPJmiR-20b overexpression is predictive of poor prognosis in gastric cancerOnco Targets Ther201581871187626244024
   PubMed Web of Science ®Google Scholar
• FanMQHuangCBGuYXiaoYShengJXZhongLDecrease expression of microRNA-20a promotes cancer cell proliferation and predicts poor survival of hepatocellular carcinomaJ Exp Clin Cancer Res20133212123594563
   PubMed Web of Science ®Google Scholar
• KnoblochKYoonUVogtPMPreferred reporting items for systematic reviews and meta-analyses (PRISMA) statement and publication biasJ Craniomaxillofac Surg2011392919221145753
   PubMed Web of Science ®Google Scholar
• TierneyJFStewartLAGhersiDBurdettSSydesMRPractical methods for incorporating summary time-to-event data into meta-analysisTrials2007811617555582
   PubMed Web of Science ®Google Scholar
• WellsGThe Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analysesAppl Eng Agric2014186727734
   Google Scholar
• SuXWangHGeWAn in vivo method to identify microRNA targets not predicted by computation algorithms: p21 targeting by miR-92a in cancerCancer Res201575142875288526062558
   PubMed Web of Science ®Google Scholar
• ÇEAktaşSTosun YildirimHMicroRNA-17, microRNA-19b, microRNA-146a, MicroRNA-302d expressions in hepatoblastoma and clinical importanceJ Pediatr Hematol Oncol2018411712
   Web of Science ®Google Scholar
• DíazRSilvaJGarcíaJMDeregulated expression of miR-106a predicts survival in human colon cancer patientsGenes Chromosom Cancer2010479794802
   Web of Science ®Google Scholar
• SuZXZhaoJRongZHWuYGGengWMQinCKDiagnostic and prognostic value of circulating miR-18a in the plasma of patients with gastric cancerTumour Biol20143512121191212525416437
   PubMedGoogle Scholar
• MaYZhangPWangFElevated oncofoetal miR-17-5p expression regulates colorectal cancer progression by repressing its target gene p130Nat Commun201231129123250421
   PubMedGoogle Scholar
• MatsumuraTSugimachiKIinumaHExosomal microRNA in serum is a novel biomarker of recurrence in human colorectal cancerBr J Cancer2015113227528126057451
   PubMed Web of Science ®Google Scholar
• ZhengJDongPGaoSWangNYuFHigh expression of serum miR-17-5p associated with poor prognosis in patients with hepatocellular carcinomaHepatogastroenterology20136012354955223108086
   PubMedGoogle Scholar
• HungCLYenCSTsaiHWSuYCYenCJUpregulation of microRNA-19b predicts good prognosis in patients with hepatocellular carcinoma presenting with vascular invasion or multifocal diseaseBMC Cancer201515166526453548
   PubMedGoogle Scholar
• YuJOhuchidaKMizumotoKFujitaHNakataKTanakaMMicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasionCancer Biol Ther201010874875720703102
   PubMed Web of Science ®Google Scholar
• XuXLJiangYHFengJGSuDChenPCMaoWMMicroRNA-17, microRNA-18a, and microRNA-19a are prognostic indicators in esophageal squamous cell carcinomaAnn Thorac Surg20149731037104524360091
   PubMed Web of Science ®Google Scholar
• FangLLiHWangLMicroRNA-17-5p promotes chemotherapeutic drug resistance and tumour metastasis of colorectal cancer by repressing PTEN expressionOncotarget20145102974298724912422
   PubMedGoogle Scholar
• WuCWDongYJLiangQYMicroRNA-18a attenuates DNA damage repair through suppressing the expression of ataxia telangiec-tasia mutated in colorectal cancerPLoS One201382e5703623437304
   PubMed Web of Science ®Google Scholar
• ChenYJWuHZhuJMMicroRNA-18a modulates p53 expression by targeting IRF2 in gastric cancer patientsJ Gastroenterol Hepatol201631115516326173586
   PubMed Web of Science ®Google Scholar
• ChenZLZhaoXHWangJWmicroRNA-92a promotes lymph node metastasis of human esophageal squamous cell carcinoma via E-cadherinJ Biol Chem201128612107251073421148309
   PubMed Web of Science ®Google Scholar
• KatadaTIshiguroHKuwabaraYmicroRNA expression profile in undifferentiated gastric cancerInt J Oncol200934253754219148490
   PubMed Web of Science ®Google Scholar
• ChenLJiangMYuanWTangHmiR-17-5p as a novel prognostic marker for hepatocellular carcinomaJ Invest Surg201225315616122583011
   PubMed Web of Science ®Google Scholar
• KeTWWeiPLYehKTChenWTChengYWMiR-92a promotes cell metastasis of colorectal cancer through PTEN-mediated PI3K/Akt pathwayAnn Surg Oncol20152282649265525515201
   PubMed Web of Science ®Google Scholar
• NamkungJKwonWChoiYMolecular subtypes of pancreatic cancer based on miRNA expression profiles have independent prognostic valueJ Gastroenterol Hepatol20163161160116726644397
   PubMed Web of Science ®Google Scholar
• ZhouTZhangGLiuZXiaSTianHOverexpression of miR-92a correlates with tumor metastasis and poor prognosis in patients with colorectal cancerInt J Colorectal Dis2013281192422772712
   PubMed Web of Science ®Google Scholar
• ZhangJXSongWChenZHPrognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysisLancet Oncol201314131295130624239208
   PubMed Web of Science ®Google Scholar
• Valladares-AyerbesMBlancoMHazMPrognostic impact of disseminated tumor cells and microRNA-17-92 cluster deregulation in gastrointestinal cancerInt J Oncol20113951253126421743960
   PubMed Web of Science ®Google Scholar
• HuYCorreaAMHoqueAPrognostic significance of differentially expressed miRNAs in esophageal cancerInt J Cancer2011128113214320309880
   PubMed Web of Science ®Google Scholar
• YuGTangJQTianMLPrognostic values of the miR-17-92 cluster and its paralogs in colon cancerJ Surg Oncol2012106323223722065543
   PubMed Web of Science ®Google Scholar
• LiuGHZhouZGChenRSerum miR-21 and miR-92a as bio-markers in the diagnosis and prognosis of colorectal cancerTumour Biol20133442175218123625654
   PubMedGoogle Scholar
• LiJLiuYWangCSerum miRNA expression profile as a prognostic biomarker of stage II/III colorectal adenocarcinomaSci Rep2015511292126250939
   PubMedGoogle Scholar
• LiBKHuangPZQiuJLLiaoYDHongJYuanYFUpregulation of microRNA-106b is associated with poor prognosis in hepatocellular carcinomaDiagn Pathol2014922625466449
   PubMed Web of Science ®Google Scholar
• KomatsuSIchikawaDTsujiuraMPrognostic impact of circulating miR-21 in the plasma of patients with gastric carcinomaAnticancer Res201333127123267156
   PubMed Web of Science ®Google Scholar
• JinHYLaiMXiaoCmicroRNA-17~92 is a powerful cancer driver and a therapeutic targetCell Cycle201413449549624419145
   PubMed Web of Science ®Google Scholar
• JungESeongYJeonBKwonYSSongHMicroRNAs of miR-17-92 cluster increase gene expression by targeting mRNA-destabilization pathwaysBiochim Biophys Acta Gene Regul Mech20181861760361229935344
   PubMed Web of Science ®Google Scholar
• YangHPengZLiangMThe miR-17-92 cluster/QKI2/β-catenin axis promotes osteosarcoma progressionOncotarget2018938252852529329861871
   PubMedGoogle Scholar
• GeorgeKChao-YiWHuang-YuYMiR-17-92 cluster and immunityJ Formos Med Assoc2018pii: S0929-6646183001630020
   Google Scholar